iShares Core MSCI EAFE ETF vs Verisign, Inc. — how do they compare? iShares Core MSCI EAFE ETF trades at $96.52 (market cap $189.19B), while Verisign, Inc. trades at $303.74 (market cap $26.92B). The key difference: iShares Core MSCI EAFE ETF is far larger — about 7× Verisign, Inc.'s market cap, and Verisign, Inc. pays a 1.09% dividend while iShares Core MSCI EAFE ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 40 Days and Verisign, Inc. for 123 Days on average.
| IEFA | VRSN | |
|---|---|---|
Market Cap | $189.19B | $26.92B |
Volume | 8,441,787 | 1,921,402 |
Sector | Broad Market / Factor | Technology |
52-Week High | $101.41 | $310.00 |
52-Week Low | $85.06 | $211.49 |
Typical Hold Time | 40 Days | 123 Days |
Enterprise Value | — | $28.23B |
Dividend Yield | — | 1.09% |
Signals from Pluang's Aura AI — not financial advice
IEFA, the iShares Core MSCI EAFE ETF, trades at $96.52, up 0.33% on the day, but technical indicators signal a bearish trend with moving averages and oscillators in sell territory. The ETF provides exposure to developed markets outside North America, holding $196 billion in assets under management and offering a competitive expense ratio of 0.07%. Recent financial news highlights its role in international diversification, comparing favorably to peers on dividend yield and cost efficiency.
The outlook for IEFA is tempered by near-term technical weakness and broader market shifts away from concentrated U.S. tech exposure. Key risks include geopolitical tensions and interest rate uncertainty, but its low-cost structure and focus on established economies provide a defensive tilt for long-term investors seeking international diversification amid S&P 500 concentration concerns.
VeriSign (VRSN) trades at $303.74, up 3.24% today, with a bullish technical outlook supported by moving averages. The stock shows strong profitability with a 49.77% net income margin and consistent revenue growth, reaching $1.66B in 2025. Recent news includes an upcoming Q3 2026 earnings call and insider selling by the CEO, while institutional buying from firms like BlackRock signals confidence. A class-action antitrust lawsuit filed in September 2026 poses a regulatory risk.
The investment outlook is positive, driven by analyst consensus favoring a buy rating with a $348 price target, implying 15% upside. Key opportunities include AI-driven domain growth and a pending .com price increase. Risks involve the antitrust litigation, competitive pressures, and reliance on domain registry revenues. Earnings momentum is mixed, with Q2 2026 missing estimates but Q1 beating expectations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →